UnknownNot Applicable

Prevalence of HCV in HIV-negative MSM

Netherlands4,000 participantsStarted 2019-10-01

Plain-language summary

This study measures the prevalence of undiagnosed hepatitis C virus (HCV) infection in HIV-negative men-who-have-sex-with-men (MSM) visiting the sexual health clinics of public health services (in dutch: gemeentelijke gezondheidsdienst, GGD), in order to evaluate if systematic screening for HCV of HIV-negative MSM attending sexual health clinics in the Netherlands is needed.

Who can participate

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Self-identifying as a man-who-has-sex-with-men (MSM) * Willing to undergo HCV testing Exclusion Criteria: * Clients known to be HIV positive

What they're measuring

HCV antibody prevalence

Timeframe: From start study to end of study, at least 2 years

Value of HCV-MOSAIC risk score in HIV-negative MSM

Timeframe: From start study to end of study, at least 2 years

Trial details

NCT IDNCT04005248

SponsorErasmus Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-12-31

Contact for this trial

Bart J.A. Rijnders, MD PhD

003110-7033510 b.rijnders@erasmusmc.nl

View on ClinicalTrials.gov More Hepatitis C Virus Infection trials